Ceres, Inc. is an agricultural biotechnology company that develops and markets seeds and traits to produce crops for feed, forages, sugar and other markets. The Company uses a combination of plant breeding, biotechnology and bioinformatics to develop seed products and biotechnology traits. Its Forage sorghum seeds are used for growing feed for livestock, including dairy and beef cattle. Its technology platforms have application across various end markets, including food, feed, fiber and fuel. It has developed bioinformatics software, Persephone, to deal with the data generated in plant genomics. Its Persephone enables storage and access to datasets, as well as data visualizations to view genetic data from public sources and databases. It markets its seed products under the name Blade. Its customers include dairies and livestock producers, agri-industrial facilities, individual growers and grower cooperatives. It deploys a range of research and development methods and tools.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry N/A
Sub-IndustryCoal & Consumable Fuels
SectorN/A
Current SymbolNASDAQ:CERE
Previous Symbol
CUSIP15677310
Phone+1-805-3766500
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
EmployeesN/A
Outstanding SharesN/A
Market Cap$0.00
OptionableNot Optionable
Ceres (NASDAQ:CERE) Frequently Asked Questions
What is Ceres' stock symbol?
Ceres trades on the NASDAQ under the ticker symbol "CERE."
How were Ceres' earnings last quarter?
Ceres Inc (NASDAQ:CERE) issued its earnings results on Thursday, April, 14th. The biotechnology company reported ($0.09) earnings per share (EPS) for the quarter. The biotechnology company had revenue of $0.35 million for the quarter, compared to analysts' expectations of $7.60 million. View Ceres' Earnings History.
Has Ceres been receiving favorable news coverage?
News headlines about CERE stock have trended very positive this week, InfoTrie reports. InfoTrie identifies positive and negative news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Ceres earned a daily sentiment score of 3.1 on InfoTrie's scale. They also gave news articles about the biotechnology company a news buzz of 8.0 out of 10, meaning that recent news coverage is very likely to have an effect on the stock's share price in the next few days.
How do I buy shares of Ceres?
Shares of CERE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Ceres' stock price today?
One share of CERE stock can currently be purchased for approximately $0.3970.
What is Ceres' official website?
How can I contact Ceres?
Ceres' mailing address is 1535 Rancho Conejo Blvd, THOUSAND OAKS, CA 91320-1440, United States. The biotechnology company can be reached via phone at +1-805-3766500.
MarketBeat Community Rating for Ceres (NASDAQ CERE)
MarketBeat's community ratings are surveys of what our community members think about Ceres and other stocks. Vote "Outperform" if you believe CERE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CERE will underperform the S&P 500 over the long term. You may vote once every thirty days.
